SO
CERE

STRS Ohio’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

STRS Ohio’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,316
Closed -$1.28M – 2097
2024
Q2 		$1.28M Buy
31,316
+18,316
+141% +$763K 0.01% 792
2024
Q1 		$549K Buy
13,000
+3,200
+33% +$134K ﹤0.01% 1193
2023
Q4 		$415K Sell
9,800
-400
-4% -$11.5K ﹤0.01% 1355
2023
Q3 		$222K Hold
10,200
– – ﹤0.01% 1543
2023
Q2 		$324K Buy
10,200
+6,300
+162% +$193K ﹤0.01% 1456
2023
Q1 		$95K Hold
3,900
– – ﹤0.01% 1722
2022
Q4 		$123K Hold
3,900
– – ﹤0.01% 1696
2022
Q3 		$110K Buy
3,900
+2,300
+144% +$68.5K ﹤0.01% 1736
2022
Q2 		$42K Hold
1,600
– – ﹤0.01% 1882
2022
Q1 		$56K Hold
1,600
– – ﹤0.01% 1931
2021
Q4 		$51K Hold
1,600
– – ﹤0.01% 2004
2021
Q3 		$47K Sell
1,600
-6,600
-80% -$185K ﹤0.01% 2080
2021
Q2 		$210K Buy
+8,200
New +$117K ﹤0.01% 1804

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

STRS Ohio's CERE Position: Q3 2024 in Review

STRS Ohio sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 31,316 shares — an estimated $1.28M sold.

STRS Ohio first reported a position in CERE in Q2 2021 and held it in 13 quarters. The position peaked at $1.28M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • STRS Ohio reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • STRS Ohio sold 31,316 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.28M.
  • STRS Ohio first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • STRS Ohio's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.28M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.